| Issue |
J Extra Corpor Technol
Volume 46, Number 3, September 2014
|
|
|---|---|---|
| Page(s) | 192 - 196 | |
| DOI | https://doi.org/10.1051/ject/201446192 | |
| Published online | 15 September 2014 | |
Invited Editorial
Understanding Off-Label Use and Reference Blood Flows in Modern Membrane Oxygenators
Address correspondence to: Gerard J. Myers, RT, CCP (Emeritus), Eastern Perfusion International, Halifax, Nova Scotia, Canada. E-mail: edit@ns.sympatico.ca
Received:
17
April
2014
Accepted:
7
August
2014
This editorial will address two issues that are still a source of global controversy and confusion in present day perfusion practice. Membrane oxygenators are designed and tested to a set of stringent flow standards prior to their release from every manufacturer. But how well do we know the iatrogenic consequences of pushing these devices beyond their maximum rated limits? In addition, how well do we know the meaning of the term ‘AAMI Reference Flow’ as it relates to the Manufacturers Maximum Rated Flow?
Key words: off-label / reference blood flow / oxygenator / gaseous microemboli / acute kidney injury / AAMI
© 2014 AMSECT
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.